Normak Laboratories Private Limited
About Normak Laboratories Private Limited
Data last updated:
Normak Laboratories Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 16 November 2009.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2009PTC196029. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹20 Lakh and a paid-up capital of ₹16 Lakh. It was led by directors Badal Kumar Banerjee and Ajay Sohanlal Midha.
Its last annual general meeting (AGM) was held on 29 October 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at 629 Dda Flats Sector – 22 Dwarka, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2017, the company reported a revenue of ₹2.79 Cr, a growth of 98% compared to the previous year. For the same year it recorded a net profit of ₹1.78 Lakh (net margin 0.6%) and EBITDA of ₹2.9 Lakh (EBITDA margin 1%).
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Company details
Contact details
Normak Laboratories Private Limited's registered office is in New Delhi, Delhi.
- Registered Address629 Dda Flats Sector – 22 Dwarka, New Delhi, Delhi, India – 110075
- IndustryHealthcare, Other Hospital And Medical Care Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Normak Laboratories is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Normak Laboratories Private Limited, buy the company report.
Financials of Normak Laboratories Private Limited
FY 2017 filings availableNormak Laboratories Private Limited reported revenue of ₹2.79 Cr (up 98% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 98% in the latest year. EBITDA rose 132% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.9 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.78 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1% | ||
| Net Profit Margin | 0.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Normak Laboratories Private Limited, buy the company report.
Board of directors of Normak Laboratories Private Limited
Normak Laboratories has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Badal Kumar Banerjee Also directs: NRSB Non Woven Fabrics LLP | Director | 16 Nov 2009 | 16 Years 11 Months | As last reported |
| Ajay Sohanlal Midha | Director | 09 Mar 2016 | 10 Years 7 Months | As last reported |
Peer comparison
Normak Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jammi Pharmaceuticals Private Limited | ₹2.8 Cr (FY 2024) | -5.0% | Chennai, Tamil Nadu, India | |||
| Devam Diagnostic Center Private Limited | ₹2.8 Cr (FY 2025) | 24.0% | Patna, Bihar, India | |||
| Vachana Diagnostics Private Limited | ₹2.8 Cr (FY 2024) | Hubli, Karnataka, India | ||||
| Saruna Medicare Private Limited | ₹2.79 Cr (FY 2023) | 9.0% | Dalanwala, Uttarakhand, India | |||
| Deepa Fortune Imaging and Diagnostics Private Limited | ₹2.79 Cr (FY 2024) | Mandya, Karnataka, India | ||||
| Normak Laboratories Private Limitedthis company | ₹2.79 Cr (FY 2017) | ₹1.78 Lakh | 0.6% | 98.0% | New Delhi, Delhi, India | |
| Shree Chakurwale Private Limited | ₹2.79 Cr (FY 2025) | -21.0% | Faridabad, Haryana, India | |||
| Utopian Healthcare Private Limited | ₹2.79 Cr (FY 2025) | 22.0% | Chennai, Tamil Nadu, India | |||
| Chaithanya Lasik Centre Private Limited | ₹2.79 Cr (FY 2024) | -12.0% | Thiruvananthapuram, Kerala, India | |||
| Upscale Healthcare Billing Solutions Private Limited | ₹2.79 Cr (FY 2025) | 43.0% | Bengaluru, Karnataka, India | |||
| Heyer Medical India Private Limited | ₹2.79 Cr (FY 2025) | 210.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Normak Laboratories Private Limited, buy the company report.
Legal cases
Normak Laboratories Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Court case (CS DJ ADJ) | Filed against the company by an individual | Pending |
To see the full case history of Normak Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Normak Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Normak Laboratories has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Normak Laboratories Private Limited, buy the company report.
Recent activity
Normak Laboratories Private Limited has 6 board changes on record since 2009: 2 appointments and 4 cessations. The latest: Kalyani Banerjee ceased to be Director on 27 Feb 2017.
Frequently asked questions
Normak Laboratories has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Normak Laboratories was a private limited company based in New Delhi, Delhi, India. The company worked in other hospital and medical care activities, within the healthcare industry. It was incorporated on 16 November 2009 and is registered under CIN U24232DL2009PTC196029. The company has been struck off by the Registrar of Companies and is no longer operational.
Normak Laboratories had 2 directors:
- Badal Kumar Banerjee - Director
- Ajay Sohanlal Midha - Director
The CIN (Corporate Identification Number) of Normak Laboratories is U24232DL2009PTC196029. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Normak Laboratories is at 629 Dda Flats Sector – 22 Dwarka, New Delhi, Delhi, India – 110075.
Normak Laboratories was incorporated on 16 November 2009. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Normak Laboratories on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 29 October 2017. Year-wise statements from 2015 are in the company report.
No. Normak Laboratories has 1 GST registration on record and it is cancelled or inactive.
Normak Laboratories operated in the healthcare industry, in the other hospital and medical care activities segment. It worked in this industry before it was struck off.
The peers of Normak Laboratories by revenue are Jammi Pharmaceuticals Private Limited, Devam Diagnostic Center Private Limited, Vachana Diagnostics Private Limited, Saruna Medicare Private Limited, Deepa Fortune Imaging and Diagnostics Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Normak Laboratories has 1 court case on record: 1 filed against it. 1 is pending.